Biomedical subjects
Publications and source records attributed to N Bom.
This study reports the development of a micromultiplane 8.2-mm transesophageal echocardiographic probe. The probe is applicable to newborn infants and can deliver diagnostic images in adults.
A new method for noninvasive pressure measurement, based on the disappearance time of micrometer-sized free gas bubbles, is described in this article. An ultrasound (US) contrast agent, consisting of encapsulated gas bubbles, is used as a vehicle to transport the free gas bubbles to the desired region where the pressure is to be measured. The small free gas bubbles are generated at the region of interest (e.g., heart chambers), from the encapsulated gas bubbles, which rupture when they are exposed to a single low-frequency (e.g., 0.5 MHz), high acoustic amplitude US burst. The released gas bubbles persist for only a few ms and dissolve in the liquid, depending on their size, the gas, the liquid characteristics and ambient parameters such as temperature, gas concentration and pressure. A pressure-disappearance time relationship is determined using a sequence of high-frequency (e.g., 10 MHz), low acoustic amplitude US pulses. From in vitro experiments, reproducible results show a significant difference between the disappearance time of the bubbles as function of the local pressure, resulting in a quicker disappearance of the bubble for higher values of the pressure. The sensitivity of the method to small pressure changes (50 mmHg) is demonstrated.
OBJECTIVE: To investigate the feasibility of using intravascular ultrasound to characterize normal and diseased renal arteries. MATERIALS AND METHODS: Forty-four renal artery specimens from 21 humans, removed at autopsy, were studied with intravascular ultrasound in vitro. From each vascular specimen, two to four sets of corresponding intravascular ultrasound images and histologic sections were subjected to qualitative analysis. The renal arterial wall was considered normal by intravascular ultrasound when the wall thickness (intima and media) was 0.5 mm or less. On intravascular ultrasound imaging, a distinction was made between bright lesions with or without peripheral shadowing (i.e. calcification). Histological sections were examined and fibromuscular lesions were scored with or without calcifications. Quantitative analysis of a multitude of intravascular ultrasound cross-sections (interval 5 mm) included assessment of the lumen area, vessel area, plaque area and percentage area obstructed. The target site (smallest lumen area) was compared with a reference site (largest lumen area before the first major side branch). RESULTS: Of the 130 corresponding intravascular ultrasound images and histologic sections analysed, 55 were normal and 75 presented a bright lesion on ultrasound; in 31 lesions, peripheral shadowing was involved. The sensitivity of the intravascular ultrasound in detecting calcifications was 87%, and the specificity was 89%. Lumen area reduction at the target site was associated with vessel and plaque area enlargement in eight specimens, with plaque area enlargement in 12 specimens and with a vessel area reduction in 21 specimens. CONCLUSIONS: Intravascular ultrasound is a reliable technique for distinguishing renal arteries with or without a lesion. Both plaque development and local vessel narrowing may result in renal artery stenosis.
Explore the source record for details and available documents.
Based on three-dimensional (3D) information, quantitative data such as plaque volume can be calculated. The procedure includes automatic contour detection based in image segmentation methods and greatly speeds up clinical evaluation. With the use of additional X-ray information, the true tortuous vessel geometry can be reconstructed in 3D. This allows, by numerical modelling techniques, to calculate endothelial shear stress values which in turn may indicate sites prone to stenosis. With a decorrelation technique for radio frequency (RF) echo information from sequential data in the same beam direction and integration method over the entire cross section, blood velocity can be shown colour-coded during the cardiac cycle, while even blood flow quantification seems to be possible. In vitro as well as animal experiments have shown the feasibility of the method. Intravascular imaging can be used to study the biomechanical properties of atheroma components. Local radial strain as a measure of local tissue hardness can be estimated in principle. Hard or soft plaques can be identified from the strain images independently of the echogenic contrast between plaque and vessel wall.
Current intravascular ultrasound techniques produce real-time imaging of a vessel cross-section with a scan plane approximately normal to blood flow. When a cluster of randomly distributed blood particles moves across the ultrasound beam, the received echo signals decorrelate as a function of time. This phenomenon may be used to estimate blood velocities by measuring the decorrelation rate from a sequence of blood scattering signals. A decorrelation-based method for measuring local blood velocity and quantifying volume flow from cross-sectional radio frequency intravascular echo signals was developed. Serial in vitro measurements were performed with a flow phantom to test the principle of the proposed velocity estimation method. An in vivo pig experiment was carried out to study the feasibility of applying this method in clinical settings. Preliminary results of this study indicate that the proposed decorrelation method is able to extract cross-sectional velocity data and volumetric flow both in vitro and in vivo.
B-mode ultrasound intima-media thickness (IMT) measurements of carotid and femoral arterial walls are used in atherosclerosis studies. In this study, the components contributing to IMT measurement variability in males with coronary artery disease were investigated by means of repeated B-mode ultrasound scans and repeated off-line video image analyses. For statistical analysis, a mixed-model analysis of variance was used. From sonographer data, it was shown that human subjects and their arterial wall segments contributed 75% of the total IMT measurement variability in this population. Inter-sonographer variance contributed 25%. The intra-sonographer variance was negligible (<1%). In off-line image analysis, variance components due to subjects and segments, inter-analyst variance, and residual fluctuation were 88%, < 1% and 11%, respectively. Intra-analyst variance was negligible (<1%). The major source of B-mode ultrasound IMT measurement variability finds its origin in subjects and their arterial walls. Although sonographers proved a lesser source of variability, in comparative studies they should enter a study well trained and should be randomly assigned to subjects. Follow-up examinations should preferably be done by the same sonographer. Off-line image analysis contributed little to IMT measurement variability.
OBJECTIVES: In this B-mode ultrasound study we assessed pravastatin treatment effects on carotid and femoral artery walls and investigated the correlations between the state and evolution of peripheral and coronary atherosclerosis. BACKGROUND: The Regression Growth Evaluation Statin Study (REGRESS) was an 11-center, 2-year, double-blind, placebo-controlled, prospective study of 885 men with coronary artery disease (CAD) (total cholesterol 4 to 8 mmol/liter). The study primarily investigated pravastatin treatment effects on the coronary lumen. This report focuses on the 255 patients who participated in the REGRESS ultrasound study. METHODS: Carotid and femoral artery walls were imaged at baseline and at 6, 12, 18 and 24 months. Pravastatin treatment effect was defined as the difference in progression of the combined intima-media thicknesses (IMT) between treatment groups. RESULTS: Pravastatin treatment effects were highly significant (combined IMT: p = 0.0085; combined far wall IMT: p < 0.0001; common femoral artery far wall IMT: p = 0.004). Correlations between the IMTs of the arterial wall segments ranged from -0.17 to 0.81. Baseline correlations between IMT and percent coronary lumen stenoses ranged from 0.23 to 0.36. Baseline IMT correlated with the mean coronary segment diameter (r = -0.32, p = 0.001) and minimal coronary obstruction diameter (r = -0.27, p = 0.005). There were no individual correlations between IMT and coronary lumen variables (p > 0.30). CONCLUSIONS: Pravastatin treatment effects on carotid and femoral artery walls were observed. B-mode ultrasound imaging studies of peripheral arterial walls could not describe the state and evolution of the coronary lumen in the individual patient, but proved to be a highly suitable tool for the assessment of antiatherosclerotic properties of agents.
IntraVascular Ultrasound Imaging (IVUS) has already been proposed in the early days of diagnostic ultrasound. Today, it has come under further full attention as a result of minimal invasive techniques. Not only excellent intravascular two-dimensional (2D) images are presently obtained, also three-dimensional (3D) reconstructed images show their diagnostic value. Based on 3D information, quantitative data such as plaque volume can be calculated. The procedure includes automatic contour detection based on image segmentation methods and greatly speeds up clinical evaluation. With the use of additional X-ray information, the true tortuous vessel geometry can be reconstructed in 3D. This allows, by numerical modelling techniques, to calculate endothelial shear stress values, which in turn may indicate sites prone to stenosis. With a decorrelation technique for radiofrequency (RF) echo information from sequential data in the same beam direction and integration method over the entire cross section, blood velocity can be shown colour-coded during the cardiac cycle, while even blood flow quantification seems to be possible. In vitro as well as in vivo experiments have shown the feasibility of the method. Intravascular imaging can be used to study the biomechanical properties of atheroma components. Local radial strain, used as a measure of local tissue hardness, can be estimated to identify hard or soft plaques independently of the echogenicity contrast between plaque and vessel wall.
OBJECTIVE: Intravascular elastography is concerned with methods for measuring the local elastic properties using intravascular ultrasound (IVUS). The elastic properties of the vessel wall and atheroma can be measured through the strain. Knowledge of these mechanical properties is useful for guiding interventional procedures (balloon dilatation, ablation) and detection of plaque vulnerability. METHODS: Elastograms and palpograms (images of strain) were constructed using the relative local displacements between IVUS images acquired at two levels of intravascular pressure with a 30-MHz echo catheter. These displacements were estimated from the time shift between gated radio-frequency echo signals using cross-correlation algorithms with interpolation around the peak. RESULTS: Experiments on gel-based phantoms mimicking atherosclerotic vessels demonstrated the capability of elastography to identify soft and hard plaques independently of the echogenicity contrast. In vitro experiments on human arteries have demonstrated the potential of intravascular elastography to identify different plaque types based on the mechanical properties. These plaques could not be identified using the IVUS image alone. Regions with elevated mechanical stress could also be detected. These stress concentrations are related to plaque fracture. CONCLUSION: Intravascular elastography provides information that is frequently unavailable or inconclusive from the IVUS image and therefore may assist in the diagnosis and treatment of atherosclerotic disease.
We present the potentials of a novel method of intracoronary flow visualization and quantification that is based on conventional intravascular ultrasound (IVUS) imaging catheters. The quantification of flow is obtained from analysis of the rate of decorrelation of digitized radiofrequency ultrasound echo signals. Flow information is superimposed on the IVUS image using a colour scale. Integration of the blood velocity components normal to the scan plane permits calculation of the volume flow. Validation using IVUS and electromagnetic (EM) flowmeter recordings were obtained in vivo from instrumented pigs. IVUS flow (IVUS(f)) compared favourably to EM flow (EM(f)): IVUS(f)=1.0 EM(f)+5.72 cc/min, r2=0.98. Clinical results for the first five patients investigated are reported. A Doppler wire was used to measure the flow in four coronary arteries and one renal artery in baseline and hyperaemia conditions. IVUS flow and derived coronary flow reserve (CFR) demonstrated a very good agreement with the data derived from the combination of quantitative angiography and velocity when measured with the Doppler wire (DOP(f)): IVUS(f)=1.01 DOP(f)-20 cc/min, r2=0.90 and IVUS(cfr)=1.03 DOP(cfr)-0.03, r2=0.93. This demonstrates that simultaneous morphological and physiological assessment of coronary or peripheral arteries with one IVUS catheter is feasible. This method should be very useful for the evaluation of intermediate coronary stenoses or the results of revascularization procedures.
BACKGROUND: Intracoronary ultrasound (ICUS) imaging is potentially suitable to identify lesions at high risk of restenosis after percutaneous transluminal coronary angioplasty (PTCA), but it has not been studied systematically. METHODS AND RESULTS: We recruited 200 patients in whom ICUS studies were performed after successful PTCA and related their ICUS parameters to 6-month follow-up quantitative coronary angiography. This was performed in 164 patients (82%), yielding 170 lesions for analysis. The overall incidence of a > or = 50% diameter stenosis at follow-up (categorical restenosis) was 29.4%. Quantitative ICUS parameters were weakly but significantly related to follow-up minimal luminal diameter on quantitative coronary angiography (lumen area: R2 = .36, P = .0001; vessel area: R2 = .29, P = .0002; plaque area: R2 = -.18, P = .021; percent obstruction: R2 = -.15, P = .05), but categorical restenosis was not significantly related to these parameters (P = .63, .77, .38, and .08, respectively). There were no significant predictors of restenosis in ICUS parameters of plaque morphology: eccentric versus concentric (P = 1.0), plaque type (hard, soft, or calcific, P = .98), or the number of calcified quadrants (P = .41). There were no significant predictors of restenosis in two predefined types of vessel-wall disruptions: (1) rupture: presence (P = .79), depth (partial versus complete, P = .85), or extent in quadrants (P = .6), and (2) dissection: presence (P = .31), depth (P = .82), or extent (P = .38). CONCLUSIONS: Qualitative ICUS parameters after PTCA did not predict restenosis. A larger lumen and vessel area and a smaller plaque area by ICUS were associated with a larger angiographic minimal lumen diameter at follow-up, but these parameters were not significantly related to categorical restenosis.
This study was performed to investigate the relationship between the cyclic variation of integrated backscatter and myocardial wall thickening in stunned myocardium. Different definitions of cyclic variation were evaluated to be able to compare with other studies. Ultrasound data were acquired from 10 open-chested Yorkshire pigs (25-33 kg) at baseline, during regional ischemia and during 30 min of stunning, using a broadband ultrasound transducer (3-7 MHz) sutured directly upon the left ventricular myocardial wall. Cyclic variation of integrated backscatter and myocardial wall thickening were calculated using three definitions obtained from the literature. Independent of the definition, cyclic variation of wall thickness and integrated backscatter were blunted during acute ischemia and returned transiently to or above baseline during the first minute of reperfusion, followed by a gradual decrease to a level under baseline during stunning. An early return of the cyclic variation of the integrated backscatter was not observed in pigs, independent of the data processing used. The relationship between integrated backscatter and wall thickness was maintained.
When blood particles travel through an intravascular ultrasound imaging plane, the received echo signals decorrelate at a rate that is related to the flow velocity. In this paper, the feasibility of extracting blood velocity from the decorrelation function of radio frequency signals was investigated through theoretical analysis and computer simulation. A computer model based on the impulse response method was developed to generate the ultrasound field of a 30-MHz intravascular transducer. The decorrelation due to the scatterer displacement as well as other nonmotion related decorrelation sources were studied. The computer simulations show that the decorrelation function is linearly related to the lateral displacement. The monotonic relationship between correlation and displacement provides possibilities to estimate flow velocity with decorrelation measurements. Because of the complexity of the beam profile in the near field, assessment of local velocities requires detailed knowledge of the decorrelation at each axial beam position. Sources of signal decorrelation other than the lateral displacement may cause a bias in the decorrelation based velocity measurements. For localized decorrelation estimation, measurement variations in small range windows present a major challenge. An approach based on multiple decorrelation measurements should be adopted in order to reduce the variations. In conclusion, results of this study suggest that it is feasible to measure flow velocity by quantifying the decorrelation of intravascular ultrasound signals from blood.
Three-dimensional (3-D) intravascular ultrasound (IVUS) allows for the visualization of entire coronary segments, provides more detailed insights into the geometry of atherosclerotic plaques and facilitates serial studies. Automated quantitative 3-D IVUS methods reduce the analysis time and the subjectivity of boundary tracing, and permit complex IVUS studies. The 3-D IVUS approach is not restricted to research applications, but may be used as a valuable clinical tool. Evaluation of the coronary segment of interest before catheter-based coronary interventions provides information which may facilitate the selection of interventional devices. Moreover, 3-D IVUS allows for a careful assessment of the procedural results and potential post-procedural complications. ECG-gated image acquisition, automated contour detection, and approaches using data of both 3-D IVUS and biplane angiography represent the recent progress in this field. Three-dimensional IVUS will surely gain further importance and become a routine technique, if the interest and research effort is sustained.
Current intravascular ultrasound techniques produce real-time imaging of a vessel cross-section with a scan plane normal to blood flow. When randomly distributed blood particles travel through this ultrasound imaging plane, the received echo signals decorrelate as a function of time. The speed of such a decorrelation procedure is proportional to the flow velocity. This phenomenon provides a potential to estimate blood velocities by means of decorrelation analysis. In this paper, we present a method for measuring local blood velocity and quantifying volume flow directly from cross-sectional intravascular ultrasound data. This method is based on multiple decorrelation assessments with a sequence of radio frequency echo signals. The velocity measurement is obtained by comparing the measured decorrelation value with the prior knowledge of the beam characteristics of an intravascular ultrasound transducer. Volume flow is derived by integrating the cross-sectional area and its corresponding velocity vector over the vessel lumen. The decorrelation-based method was tested in vitro with a flow phantom. Measurements were also carried out in vivo in pig experiments to determine the usefulness of this method in clinical settings. Preliminary results of these experiments indicate that the proposed decorrelation method is able to extract cross-sectional velocity profiles and volumetric flow both in vitro and in vivo.
After its introduction about two decades ago, transesophageal echocardiography (TEE) has rapidly evolved into an important diagnostic feature for the cardiologist, since it offers anatomic and hemodynamic information which cannot be obtained precordially. Part of this success was due to the developments in transducer technology which resulted in smaller probes with progressively better imaging qualities. A short review of past, recent and future developments of TEE phased array probes, in particular those at the Erasmus University in Rotterdam, will be given. Furthermore, this article discusses basic parameters of the transducer dictating image quality such as centre frequency, array aperture and focusing illustrated with several simulations. The simulations show that a poor design of the transducer will limit the resolution and will give artefacts in the two-dimensional image.
To investigate the independent effect of myocardial wall thickness and myocardial perfusion pressure on integrated backscatter, experiments were designed in which integrated backscatter of normally perfused myocardial tissue was measured while changes in wall thickness during the cardiac cycle were reduced to a minimum. In nine blood-perfused isolated pig hearts, perfusion pressure was uncoupled from left ventricular pressure generation (Langendorff method) and isovolumic contraction and relaxation were realized by inserting a noncompressible water-filled balloon into the left ventricle. In a first experiment, at constant perfusion pressure (85 mmHg), the integrated backscatter (3-7 MHz), the myocardial wall thickness and the left ventricular pressure were determined simultaneously at various balloon volumes (5-25 mL). A quasistatic increase of balloon volume by 50% resulted in an average decrease of wall thickness of 6.5% (p < 0.01) and a mean increase in the integrated backscatter level of 1.1 dB (p < 0.01). Integrated backscatter levels increased statistically significant by 0.14 +/- 0.014 dB per percent decrease of wall thickness. Measurements of percentage end-systolic myocardial wall thickening ranged from -10% to +10%, mean 0.15 +/- 4.5% (NS from zero); whereas cyclic variation of integrated backscatter ranged from -3.9 to +3.9 dB, mean 0.19 +/- 1.5 dB (NS from zero). In a second experiment, at a constant midrange balloon volume, the same parameters were determined simultaneously at various perfusion pressures (20-120 mmHg). An increase in perfusion pressure by 50% resulted in a small but statistically significant increase of 1.5% in myocardial wall thickness, which could be explained by an increase of intravascular volume. The integrated backscatter levels did not change statistically significantly. Measurements of percentage end-systolic myocardial wall thickening ranged from -8.9 to +7.8%, mean 0.13 +/- 4.0% (NS from zero); whereas cyclic variation of integrated backscatter ranged from -1.8 to +4.2 dB, mean 0.37 +/- 1.3 dB (NS from zero). The magnitude of cyclic variation of integrated backscatter of myocardial tissue in a contractile state is reduced if myocardial muscle is prevented from normal thickening. In addition, changes in intravascular volume during the cardiac cycle have a negligible influence on the absolute backscatter level or its cyclic variation. We conclude, if only wall thickness and perfusion pressure are involved, that integrated backscatter is mainly determined by myocardial wall thickness.